OTCMKTS:CSLLY

CSL - CSLLY Stock Forecast, Price & News

$91.25

-1.34 (-1.45%)

(As of 09/30/2022 12:00 AM ET)

Add

Compare

Today's Range: $91.25
▼
$92.75
50-Day Range: $90.51
▼
$104.62
52-Week Range: $85.07
▼
$117.24

Volume: 149,145 shs
Average Volume: 59,759 shs
Market Capitalization: $88.00 billion

P/E Ratio: N/A
Dividend Yield: 1.17%
Price Target: N/A

CSL MarketRank™ Forecast

Analyst Rating: N/A
Upside/Downside: N/A
Short Interest: Healthy
0.00% of Shares Sold Short
Dividend Strength: Weak
Based on Four Factors
Sustainability: N/A
News Sentiment: 0.31
Based on 5 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: 20.80%
From $2.74 to $3.31 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.71 out of 5 stars

N/A

Analyst's Opinion

Consensus Rating
There is not enough analysis data for CSL.

3.0

Short Interest

Percentage of Shares Shorted
0.00% of the outstanding shares of CSL have been sold short.
Short Interest Ratio / Days to Cover
CSL has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in CSL has recently increased by 81.82%, indicating that investor sentiment is decreasing significantly.

1.7

Dividend Strength

Dividend Yield
CSL pays a meaningful dividend of 1.17%, higher than the bottom 25% of all stocks that pay dividends.
Dividend Growth
CSL does not have a long track record of dividend growth.
Dividend Sustainability
Based on earnings estimates, CSL will have a dividend payout ratio of 32.63% next year. This indicates that CSL will be able to sustain or increase its dividend.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for CSLLY.

1.8

News and Social Media Coverage

News Sentiment
CSL has a news sentiment score of 0.31. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.81 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 5 news articles for CSL this week, compared to 2 articles on an average week.
MarketBeat Follows
Only 2 people have added CSL to their MarketBeat watchlist in the last 30 days. This is a decrease of -60% compared to the previous 30 days.

0.0

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, CSL insiders have not sold or bought any company stock.
Percentage Held by Institutions
Only 0.06% of the stock of CSL is held by institutions.

1.9

Earnings and Valuation

Earnings Growth
Earnings for CSL are expected to grow by 20.80% in the coming year, from $2.74 to $3.31 per share.
Price to Book Value per Share Ratio
CSL has a P/B Ratio of 6.03. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About CSL (OTCMKTS:CSLLY) Stock

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The CSL Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza related products. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.

Receive CSLLY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CSL and its competitors with MarketBeat's FREE daily newsletter.

CSLLY Stock News Headlines

September 29, 2022 | americanbankingnews.com

CSL Limited (OTCMKTS:CSLLY) Short Interest Update

September 29, 2022 | americanbankingnews.com

Critical Contrast: CSL (OTCMKTS:CSLLY) versus Rhythm Pharmaceuticals (NASDAQ:RYTM)

September 27, 2022 | fool.com.au

When might the CSL share price top $300 again?

September 24, 2022 | msn.com

Per BMW, the CSL's top speed is 191 mph. This one goes 192 with ease.

September 24, 2022 | americanbankingnews.com

CSL (OTCMKTS:CSLLY) Upgraded to "Buy" by Jefferies Financial Group

September 23, 2022 | msn.com

2023 BMW M4 CSL Outruns Itself In Top Speed Autobahn Blast

September 21, 2022 | uk.finance.yahoo.com

Carlisle (CSL) Stock Moves -1.65%: What You Should Know

September 21, 2022 | fool.com.au

Could the CSL share price be set for a boost before the year’s end?

September 20, 2022 | uk.finance.yahoo.com

4 Reasons Why You Should Invest in Carlisle (CSL) Stock Now

September 16, 2022 | fool.com.au

The CSL share price has gone backwards in 2022. Could a turnaround be ‘just starting to happen’?

September 12, 2022 | fool.com.au

Can the CSL share price regain its 52-week high in 2022?

September 8, 2022 | fool.com.au

The CSL share price is still trading just 10% above its COVID-crash low. Is it a buy?

September 6, 2022 | msn.com

2023 BMW M4 CSL Acceleration Test Shows Claimed Stats In Action

August 22, 2022 | seekingalpha.com

CSL Limited: Market's Focus Is On Guidance And Recent Acquisition

August 22, 2022 | finance.yahoo.com

Travere, CSL's Sparsentan Application Is Under European Review For Rare Kidney Disorder

August 17, 2022 | reuters.com

Australia biotech giant CSL reports profit dip, flags cost spiral

August 17, 2022 | nz.finance.yahoo.com

CSL FY net profit dips to $A3.2bln

August 17, 2022 | nasdaq.com

Australia shares flat as miners offset CSL drag, NZ falls ahead of rates decision

August 17, 2022 | msn.com

CSL flags higher costs after FY profit dip

August 16, 2022 | au.finance.yahoo.com

CSL full-year net profit dips

August 16, 2022 | fool.com.au

CSL share price on watch following FY22 results

August 16, 2022 | fool.com.au

Looking to buy CSL shares? Here’s what to watch when the biotech reports this week

August 11, 2022 | reuters.com

Dalian coach thanks fans for relaying instructions in CSL game

August 8, 2022 | fool.com.au

CSL share price climbs as $16 billion Vifor acquisition becomes effective

August 5, 2022 | msn.com

BMW M3 CSL Uses The Whole Speedometer In Autobahn Run

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive CSLLY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CSL and its competitors with MarketBeat's FREE daily newsletter.

CSLLY Company Calendar

Today: 10/01/2022
Fiscal Year End: 6/30/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Industry: Pharmaceutical preparations
Sub-Industry: N/A
Sector: Medical
Current Symbol: OTCMKTS:CSLLY
CUSIP: N/A
CIK: 1274152
Web: www.csl.com.au
Phone: (139) 389-1911
Fax: 61-3-9389-1434
Employees: 30,000
Year Founded: 1904

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: 0.35
Current Ratio: 2.32
Quick Ratio: 1.71

Sales & Book Value

Annual Sales: $10.56 billion
Price / Sales: 8.33
Cash Flow: $2.99 per share
Price / Cash Flow: 30.52
Book Value: $15.13 per share
Price / Book: 6.03

Miscellaneous

Outstanding Shares: 964,430,000
Free Float: N/A
Market Cap: $88.00 billion
Optionable: Not Optionable
Beta: 0.68

Key Executives

Mr. Paul R. Perreault B.A. (Age 65)
MD, CEO & Exec. Director
Comp: $4.87M

Ms. Joy Carolyn Linton B.Com. (Age 57)
BComm, GAICD, Grad Dip AFI, Chief Financial Officer
Comp: $2.15M

Dr. Paul F. McKenzie Ph.D. (Age 56)
Chief Operating Officer
Comp: $2.32M

Mr. Mark Dehring
Head of Investor Relations

Mr. Gregory Boss B.S. (Age 61)
BS(Hons), J.D., Exec. VP of Legal & Group Gen. Counsel

Christina Hickie
Sr. Mang. of Communications

Ms. Elizabeth Walker B.A. (Age 52)
M.S., Exec. VP & Chief HR Officer

Dr. Karen Etchberger (Age 64)
Exec. VP of Quality & Bus. Services

Dr. Wilfried Freudenberg
Department Head of Albumin & Immunoglobulins Production

Ms. Jemimah Brennan
Head of Communications - Asia Pacific

Key Competitors

View All Competitors

CSLLY Stock - Frequently Asked Questions

Should I buy or sell CSL stock right now?: 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for CSL in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" CSLLY shares.
View CSLLY analyst ratings or view top-rated stocks.
How have CSLLY shares performed in 2022?: CSL's stock was trading at $105.80 at the beginning of the year. Since then, CSLLY stock has decreased by 13.8% and is now trading at $91.2450.
View the best growth stocks for 2022 here.
Are investors shorting CSL?: CSL saw a increase in short interest in September. As of September 15th, there was short interest totaling 8,000 shares, an increase of 81.8% from the August 31st total of 4,400 shares. Based on an average daily trading volume, of 71,700 shares, the days-to-cover ratio is currently 0.1 days.
View CSL's Short Interest.
Is CSL a good dividend stock?: CSL (OTCMKTS:CSLLY) pays an annual dividend of $1.08 per share and currently has a dividend yield of 1.17%.
Read our dividend analysis for CSLLY.

What is CSL's stock symbol?: CSL trades on the OTCMKTS under the ticker symbol "CSLLY."
How do I buy shares of CSL?: Shares of CSLLY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is CSL's stock price today?: One share of CSLLY stock can currently be purchased for approximately $91.25.
How much money does CSL make?: CSL (OTCMKTS:CSLLY) has a market capitalization of $88.00 billion and generates $10.56 billion in revenue each year.
How many employees does CSL have?: The company employs 30,000 workers across the globe.
How can I contact CSL?: CSL's mailing address is 45 Poplar Road, Parkville C3, 3052. The official website for the company is www.csl.com.au. The company can be reached via phone at (139) 389-1911, via email at bernard.ronchi@csl.com, or via fax at 61-3-9389-1434.

This page (OTCMKTS:CSLLY) was last updated on 10/1/2022 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

MarketBeat Resources